Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Long-Term Deferred Tax (2020)

Historic Long-Term Deferred Tax for Tango Therapeutics (TNGX) over the last 1 years, with Q4 2020 value amounting to $31262.0.

  • Tango Therapeutics' Long-Term Deferred Tax changed N/A to $31262.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $31262.0, marking a year-over-year change of. This contributed to the annual value of $31262.0 for FY2020, which is N/A changed from last year.
  • Per Tango Therapeutics' latest filing, its Long-Term Deferred Tax stood at $31262.0 for Q4 2020.
  • Over the past 5 years, Tango Therapeutics' Long-Term Deferred Tax peaked at $31262.0 during Q4 2020, and registered a low of $31262.0 during Q4 2020.